Login

FREE TRIAL  Receive 30 days of no-obligation access. SIGN UP

Home

Top Story

Dems Make Push For One-Year APTC Extension

Democratic health leaders are pitching to Republicans a one-year extension of the enhanced Affordable Care Act tax credits, armed with a new Congressional Budget Office analysis showing millions would be uninsured and gross premiums would increase if the credits that expire at the end of 2025 aren’t available extended.

Lame-Duck Showdown

Dems’ Counter Lame Duck Proposal: Two-Year Telehealth Extender, CHC Funding Boost, Prior Auth Reform

Congressional Democrats’ counteroffer to Republicans’ lame-duck health care offer includes a two-year extension of Medicare telehealth flexibilities versus Republican’s three-year extension, a small boost in community health center funding, prior authorization requirements, a two-year extension of most expiring programs and No Surprise Act funding -- along with language similar to Republicans’ on a physician payment patch, pharmacy benefit manager reforms and a bipartisan Medicaid effort, several lobbyists say.

Analyst Suggests Nursing Home Staff Rule Delay Versus Repeal In Play

Transition 2025

RFK Jr. Seeks Pro-Raw Milk Advisor As USDA Begins Mandatory Testing

The U.S. Department of Agriculture (USDA) is launching a national milk testing strategy to detect the spread of highly pathogenic avian influenza (HPAI or H5N1), the department announced Friday (Nov. 6) as the Biden administration draws to an end.

Blackburn’s Proposed Fed Spending Cuts Would Include Public Health Agencies

More Coverage →

Latest News

Hospitals, clinics and other providers subject to Section 1557 must meet federal requirements around providing patients free interpretation services by July 5, 2025, HHS’ Office of Civil Rights said Thursday (Dec. 5) in a letter, which also directed providers using artificial intelligence to translate communications into different languages to have qualified interpreters review them for accuracy as soon as possible.

The Safe Step Act, a bipartisan, bicameral bill requiring employer plans to establish a clear exceptions process for medication step therapy, would boost access to prescribed drugs but would likely increase premiums for those plans while reducing federal revenue by $2 billion over a decade, according to Congressional Budget Office score out Thursday (Dec. 5).

FDA has issued a new draft guidance on accelerated approval drugs that sets out guidelines for how confirmatory trials should be conducted and how surrogate endpoints should be considered but leaves some of the biggest questions about the pathway, including how swiftly FDA will withdraw drugs if confirmation isn’t provided, unanswered.